Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz-Josef Neumann

Showing results (371-380 of 477) with videos related to

Pageof 48
Sort By:
Circulation|December 28, 2018
Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II TrialHolger Thiele, Uwe Zeymer, Nathalie Thelemann, et al.
The New England Journal of Medicine|August 16, 2008
Bivalirudin versus unfractionated heparin during percutaneous coronary interventionAdnan Kastrati, Franz-Josef Neumann, Julinda Mehilli, et al.
Lancet (London, England)|September 10, 2013
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trialHolger Thiele, Uwe Zeymer, Franz-Josef Neumann, et al.
Annals of Internal Medicine|July 21, 2020
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized TrialMaurizio Menichelli, Franz-Josef Neumann, Gjin Ndrepepa, et al.
Circulation. Cardiovascular Interventions|March 1, 2021
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting StentAjay J Kirtane, Robert Stoler, Robert Feldman, et al.
Circulation|December 7, 2007
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trialStephen D Wiviott, Dietmar Trenk, Andrew L Frelinger, et al.
JACC. Cardiovascular Interventions|July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES StudySorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
Circulation|February 16, 2011
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fractionNikolaus Jander, Jan Minners, Ingar Holme, et al.
American Heart Journal|September 10, 2018
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stentsChristine J Chung, Ajay J Kirtane, Yiran Zhang, et al.
Circulation|November 28, 2013
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) studyBernhard Witzenbichler, Akiko Maehara, Giora Weisz, et al.
Pageof 48

Showing results (371-380 of 477) with videos related to

Sort By:
Pageof 48
Circulation|December 28, 2018
Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II TrialHolger Thiele, Uwe Zeymer, Nathalie Thelemann, et al.
The New England Journal of Medicine|August 16, 2008
Bivalirudin versus unfractionated heparin during percutaneous coronary interventionAdnan Kastrati, Franz-Josef Neumann, Julinda Mehilli, et al.
Lancet (London, England)|September 10, 2013
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trialHolger Thiele, Uwe Zeymer, Franz-Josef Neumann, et al.
Annals of Internal Medicine|July 21, 2020
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized TrialMaurizio Menichelli, Franz-Josef Neumann, Gjin Ndrepepa, et al.
Circulation. Cardiovascular Interventions|March 1, 2021
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting StentAjay J Kirtane, Robert Stoler, Robert Feldman, et al.
Circulation|December 7, 2007
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trialStephen D Wiviott, Dietmar Trenk, Andrew L Frelinger, et al.
JACC. Cardiovascular Interventions|July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES StudySorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
Circulation|February 16, 2011
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fractionNikolaus Jander, Jan Minners, Ingar Holme, et al.
American Heart Journal|September 10, 2018
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stentsChristine J Chung, Ajay J Kirtane, Yiran Zhang, et al.
Circulation|November 28, 2013
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) studyBernhard Witzenbichler, Akiko Maehara, Giora Weisz, et al.
Pageof 48